Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Goodwin Advises Virtustream in $1.2 Billion Sale to EMC

Related Content

Acting Comptroller Discusses Frameworks to Identify Systemic Risk

CFPB Finalizes Personal Financial Data Rights Rule

UK Employment: A Sea Change Ahead

California Expands Scope of Rosenthal Act to Cover Commercial Financial Transactions

OCC Issues Bulletin on Refinance Risk in Commercial Lending

CFPB Issues Advisory Opinion on FDCPA Compliance for Medical Debt

Governor Vetoes California Assembly Bill 3129, Regulating Private Equity- and Hedge Fund-backed Healthcare Transactions

CFPB Proposes Amendment to Remittance Transfer Rule

Aerovate Therapeutics to Combine with Jade Biosciences in All-Stock Transaction

Goodwin Advises HLTH in its Acquisition by Hyve

Goodwin Advises CareBridge in Acquisition by Elevance Health

Joshua Zachariah Named a Law360 MVP in Mergers & Acquisitions

Strafford Webinar: Private Equity Take-Private Transactions: Deal Structures, Financing Considerations, Advantages and Disadvantages

Zuora To Be Taken Private By Silver Lake and GIC in $1.7 Billion Transaction

Goodwin Once Again Number One for M&A

Virios Therapeutics and Wex Pharmaceuticals Agree to Business Combination to Form Dogwood Therapeutics

Technology

Mergers & Acquisitions

Strategic Technology Transactions and Licensing

Tax

ERISA & Executive Compensation

Antitrust & Competition

Global Trade

Technology M&A